Kyowa joins GSK in Tim-3
Meanwhile, Tango tries again in PRMT5.
Blood cancer gene therapies enter the clinic
First-in-human trial initiations feature Interius, Umoja and Vironexis.
Meanwhile, Tango tries again in PRMT5.
First-in-human trial initiations feature Interius, Umoja and Vironexis.
